Significantly, PHGDH is amplified in a number of cancers, including breast cancer, melanoma, lung cancer, colon cancer, and neuroendocrine prostate cancer (NEPC), and higher PHGDH expression is associated with increased serine biosynthesis and poorer survival and prognosis [110,111,118]. The gene discussed is PHGDH; the disease is breast carcinoma.